XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Equity Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Equity Compensation [Abstract]  
Schedule of Equity Compensation Expense and Related Income Tax Benefit Recognized
The following table summarizes the equity compensation expense and related income tax benefit recognized in the Consolidated Statements of Income (in thousands): 

 
Three Months Ended
March 31,
 
2019
 
2018
Restricted awards:
 
 
 
Pre-tax compensation expense
$
1,163

 
$
936

Tax benefit
297

 
239

Restricted stock expense, net of tax
$
866

 
$
697

Performance awards:
 
 
 
Pre-tax compensation expense
$
896

 
$
485

Tax benefit
228

 
124

Performance award expense, net of tax
$
668

 
$
361

Schedule of Equity Compensation Stock Options Activity
The following table summarizes stock option activity for the three months ended March 31, 2019:

 
Number of
Options
(in thousands)
 
Weighted
Average
Exercise
Price ($)
 
Weighted
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic Value
(in thousands)
Outstanding at beginning of period
9

 
$
19.02

 

 

Granted

 

 

 

Exercised

 

 

 

Forfeited

 

 

 

Expired

 

 

 

Outstanding at end of period
9

 
19.02

 
0.68
 
$
136

Exercisable at end of period
9

 
19.02

 
0.68
 
$
136

Schedule of Equity Compensation, Restricted Award Activity
The following table summarizes restricted award activity for the three months ended March 31, 2019:

 
Number of
Restricted
Awards (in
thousands)
 
Weighted
Average Grant
Date Fair
Value ($)
Nonvested at beginning of period
326

 
$
31.93

Granted
132

 
33.05

Vested
(45
)
 
33.62

Forfeited
(3
)
 
30.78

Nonvested at end of period
410

 
32.12

Schedule of Equity Compensation Performance Award Activity
The following table summarizes performance award activity for the three months ended March 31, 2019:

 
Number of
Performance
Awards (in
thousands)
 
Weighted
Average Grant
Date Fair
Value ($)
Nonvested at beginning of period
207

 
$
27.92

Granted
97

 
32.88

Vested
(35
)
 
27.07

Forfeited

 

Nonvested at end of period
269

 
29.83